Akoya Biosciences, Inc.

AKYA · NASDAQ
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Assets
Cash & Equivalents$20,357$11,779$12,557$8,923
Short-Term Investments$7,187$23,261$23,339$36,301
Receivables$11,742$13,779$12,786$16,554
Inventory$22,853$24,321$25,212$24,796
Other Curr. Assets$4,073$3,592$2,967$2,938
Total Curr. Assets$66,212$76,732$76,861$89,512
Property Plant & Equip (Net)$12,086$12,983$13,973$14,472
Goodwill$18,262$18,262$18,262$18,262
Intangibles$13,845$14,559$15,272$15,986
Long-Term Investments$0$0$3,399$3,496
Tax Assets$0$0$0-$4,200
Other NC Assets$2,244$2,469$2,206$6,217
Total NC Assets$46,437$48,273$53,112$54,233
Other Assets$0$0$0$0
Total Assets$112,649$125,005$129,973$143,745
Liabilities
Payables$10,291$8,759$8,760$9,785
Short-Term Debt$76,487$3,283$3,677$3,322
Tax Payable$0$0$0$0
Deferred Revenue$7,586$6,554$7,377$6,461
Other Curr. Liab.$1,926$3,151-$2,267$4,986
Total Curr. Liab.$108,082$29,444$27,993$32,738
LT Debt$0$76,182$75,902$75,684
Deferred Rev, NC$2,782$3,063$3,093$3,170
Deferred Tax Liab, NC$140$129$113$75
Other NC Liab.$3,512$3,911$3,899$4,137
Total NC Liab.$10,456$87,966$88,347$88,758
Other Liabilities$0$0$0$0
Cap. Leases$7,236$7,964$9,017$9,014
Total Liabilities$118,538$117,410$116,340$121,496
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$2$2
Retained Earnings-$301,088-$285,436-$277,237-$266,704
AOCI-$1$7$8-$12
Other Equity$0$0$0$0
Total Equity-$5,889$7,595$13,633$22,249
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$112,649$125,005$129,973$143,745
Net Debt$56,130$67,686$67,022$70,083